Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study (Q40131795)

17 September 2017

title

Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study (English)

1 reference

17 September 2017

Jiang Long

1

1 reference

17 September 2017

Jia-sheng Zheng

series ordinal

2

1 reference

17 September 2017

Bin Sun

series ordinal

3

1 reference

17 September 2017

Ningning Lu

series ordinal

4

1 reference

17 September 2017

publication date

7 January 2016

1 reference

17 September 2017

published in

Hepatology international

1 reference

17 September 2017

volume

10

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

175-184

1 reference

https://scigraph.springernature.com/pub.10.1007/s12072-015-9673-6

17 September 2017

exact match

0 references

cites work

Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolizat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Radiofrequency versus microwave ablation in a hepatic porcine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Mass reduction by radiofrequency ablation before hepatic arterial infusion chemotherapy improved prognosis for patients with huge hepatocellular carcinoma and portal vein thrombus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

VEGF is essential for the growth and migration of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Combination of radiofrequency ablation and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

Stage IV hepatocellular carcinoma with portal venous tumor thrombus: complete response after combined therapy of repeated arterial chemoembolization and radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-015-9673-6

[Significance of typing of tumor thrombi in determination of treatment and assessment of prognosis of hepatocellular carcinoma with tumor thrombi in the portal vein]

21 January 2018

1 reference

12 December 2020

Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel

1 reference

12 December 2020

Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study

1 reference

12 December 2020

A specific cytotoxic T-lymphocyte epitope presentation system for antitumor immunity

1 reference

12 December 2020

Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus

1 reference

12 December 2020

Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis

1 reference

12 December 2020

Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer

1 reference

12 December 2020

Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S12072-015-9673-6

Identifiers

DOI

1 reference

release_kbzhj5vprrgbxaa6z37oesx6oa

17 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kbzhj5vprrgbxaa6z37oesx6oa

24 November 2022

mapped directly with Wikidata item

1 reference